About Geneseeq
Geneseeq is a research-driven company that provides cutting-edge genomic profiling technology to accelerate precision cancer care. Our Canadian and Chinese headquarters focus on clinical genetic testing and translational research, covering all cancers and sample types.
Our Expertise
Our genomic testing services offer both pan-cancer panels analyzing 400+ genes and cancer-type specific gene panels to help match a patient to the optimal treatment, including targeted therapy and immunotherapy. Our research services providing high-quality genomic data by next-generation sequencing with fast turnaround time to accelerate translational research.
Comprehensive genetic testing
Next-generation sequencing
AI-Powered bioinformatics
Biomarker discovery
Toronto Headquarters
Headquartered in downtown Toronto since 2012, Geneseeq Canada currently employs 30+ passionate professionals driving innovation and excellence.
Our Next Generation Sequencing (NGS) laboratory, located in Mississauga, Canada, is equipped with advanced technology to support comprehensive genomic analysis and deliver precise results. Strategically located just 10 minutes from Canada’s largest airport, supporting us as a trusted partner for seamless logistics and global collaboration.
Improving Patient Outcomes
Our genomic testing services offer both pan-cancer panels analyzing 400+ genes and cancer-type specific gene panels to help match a patient to the optimal treatment, including targeted therapy and immunotherapy. Our research services providing high-quality genomic data by next-generation sequencing with fast turnaround time to accelerate translational research.
Our Science
At Geneseeq, our R&D efforts in translational research play a key role in discovering novel biomarkers that are capable of guiding treatment strategies and transforming lives.
We continue to seek collaborations with both institutional and biopharma partners. To date, we have 3,000+ clinical research projects and published 950+ translational research papers in peer-reviewed journals.
3,000+
CLINICAL PROJECTS
in translational research
950+
PUBLICATIONS
with total IF 6,500+
Chinese Headquarters
Geneseeq’s Chinese headquarters are located in Nanjing’s High-Tech District with 1500+ staff and 10+ offices across China. The 400,000 sqft Nanjing location houses a state-of-the-art CAP/CLIA/ISO15189 accredited clinical testing center with multiple high throughput NGS platforms and an ISO13485 certified diagnostic kit manufacturing facility for NGS CDx kit production.
Our Reach
Our products and services are well established and trusted as they are ordered by 8,000+ oncologists from 800+ hospitals across China’s 25 provinces. We also engaged in 3,000+ translational research projects and supported 150+ biopharmaceutical companies in their clinical trials.
8,000+
ONCOLOGISTS
ordered our genetic tests
800+
HOSPITALS
in which our products are used
350,000+
SAMPLES
testing capacity per year
150+
PARTNERS
in biopharma
JOIN OUR NEWSLETTER
LET’S ACCELERATE PRECISION CANCER CARE, TOGETHER.
Learn more about our products and services or contact us today to discuss how we can partner together.
